Delivery Order SPE2DB22D1103-SPE2DB25FTMN5

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,705.97, is for the delivery of 120 tablets of the prescription drug Mesalamine delayed-release 1.2 gram. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $5,180.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,562,817,232 units of the drug Mesalamine DR 1.2 GM Tablet 120S. The contract has an ultimate completion date of November 15, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,620.66 contract is for the delivery of 180 units of Mesalamine 800 mg delayed-release tablets. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $1,494.65 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567696122 MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, with an ultimate completion date of March 27, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,713,896 tablets of the medication Mesalamine DR 1.2 gram, with a ceiling value of $5,692.07. The contract is a firm fixed price delivery order with a period of performance extending to February 21, 2024. This award is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,942,947 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has a ceiling value of $2,002.92 and a completion date of April 17, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,764.68, is for the delivery of 4567679036 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of March 25, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,016.35, is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,032.04, is for the supply of 4,564,460,385 units of the pharmaceutical product Mesalamine DR 1.2 GM Tablet 120S. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,712 units of the medication Mesalamine DR 400 mg capsule in 180-count bottles. The delivery order, valued at $15,721.70, has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTMN5
    Delivery Order

This is a $3,654.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,231,508 units of the medication Mesalamine DR 1.2 GM Tablet 120S. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle extending through December 2026. The contract is not designated as a set-aside. This delivery order will support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 11:49 AM